# Labeling Guidelines

## Objective
Ensure consistent labeling of tumor samples as malignant or benign.

## Decision Criteria
- Use pathology-confirmed diagnosis as source of truth.
- In ambiguous cases, escalate to expert review and capture rationale.

## Quality Controls
- Maintain gold set of 50 samples reviewed by senior oncologist.
- Target inter-annotator agreement â‰¥ 0.95 (Cohen's kappa).
- Audit 10% of new labels weekly.

## Tooling
- Use secure labeling platform with PII redaction.
- Log annotator IDs and timestamps for audit trail.
